Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer’s disease

Javier María Peralta Ramos; Giulia Castellani; Denise Kviatcovsky; Tommaso Croese; Afroditi Tsitsou-Kampeli; Chiara Burgaletto; Miguel Angel Abellanas; Liora Cahalon; Sarah Phoebeluc Colaiuta; Tomer‐Meir Salame; Yael Kuperman; Alon Savidor; Maxim Itkin; Sergey Malitsky; S Ovadia; Shir Ferrera; Limor Kalfon; Shiran Kadmani; Nadra Nasser Samra; Rotem Paz; Lior Rokach; Roberto Furlan; Judith Aharon‐Peretz; Tzipora C. Falik‐Zaccai; Michal Schwartz

doi:10.1038/s41467-025-58494-y

Related publications

Article2009

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

Sandra L. Siedlak, Gemma Casadesús, Kate M. Webber, Miguel A. Pappolla, Craig Atwood, Mark A. Smith, George Perry

Article2013

Microsomal prostaglandin E synthase‐1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease‐like pathology in a mouse model

Yoshiharu Akitake, Yoshihito Nakatani, Daisuke Kamei, Masato Hosokawa, Hiroyasu Akatsu, Satoshi Uematsu, Akira Shizuo, Ichiro Kudo, Shuntaro Hara, Mitsuo Takahashi

Journal of Neuroscience Research

Article2014

Effect of nutritional supplement therapies in the prevention of Alzheimer’s disease in a transgenic mouse model

Matthew J. Sharman, Daniel Ong, Giuseppe Verdile, Gerald Münch, Markus R. Wenk, Barry Halliwell, Ralph N. Martins

Article2003

A Metabolic Basis for Alzheimer Disease

George Perry, Akihiko Nunomura, Arun K. Raina, Gjumrakch Aliev, Sandra L. Siedlak, Peggy L.R. Harris, Gemma Casadesús, Robert B. Petersen, William Z. Bligh-Glover, Elizabeth K. Balraj, Grace J. Petot, Mark A. Smith

Letter2006

The Fallacy of Amyloid and Cognition in Alzheimer???s Disease

Hyoung‐gon Lee, Xiongwei Zhu, George Perry, Mark A. Smith